Compliance Law360 provides cutting-edge news and analysis of interest to corporate compliance officers and the lawyers and consultants who advise them. From real-time information and data on regulation and enforcement to incisive features on the increasing demands facing chief compliance officers in today’s world, the wire aims to be a one-stop shop for CCOs looking to stay abreast with a complex world.

Sign up for a 7-day FREE trial today!

Latest News in Compliance

• November 03, 2025

  MIT Bros Rest, Expert Says $25M Crypto Score Was Aboveboard

  Two MIT-educated brothers accused of using an unlawful crypto trading strategy to steal $25 million from other traders on Monday rested their case without taking the stand, after a defense expert witness said they didn't violate any rules of the Ethereum blockchain.

• November 03, 2025

  CarMax's Hype Over Sales Ignored Tariff Fears, Investors Say

  CarMax investors filed a proposed securities class action in Maryland federal court Monday alleging its executives recklessly overhyped the used vehicle seller's growth potential and assured positive results for "years to come" when it should have known its sales bump was due to consumers purchasing cars ahead of anticipated tariffs.

• November 03, 2025

  Global Privacy Regulators Set Sights On Kids' Data Protection

  A global network of more than 30 national data protection authorities is conducting an enforcement sweep to examine how websites and mobile apps commonly used by children are handling and protecting minors' personal information, the group announced Monday. 

• November 03, 2025

  Pharmacies Seek Cert. In Cholesterol Drug Price-Fixing MDL

  A group of indirect reseller plaintiffs urged a Pennsylvania federal judge on Friday to certify a nationwide class of thousands of pharmacies that indirectly purchased the cholesterol medication pravastatin in sprawling multidistrict litigation over alleged price-fixing in the generic drug industry.

• November 03, 2025

  Biotech Co. Agrees To Reforms After Co-Founder's Conviction

  Executives of the company formerly known as Enochian BioSciences Inc. have agreed to implement a series of corporate reforms to end shareholder derivative claims that they breached their fiduciary duty when a company co-founder it hailed as a "genius" was accused of both a murder-for-hire plot and falsifying research data.

See more Compliance news